Product Information
17474-1-AP targets LYG1 in WB, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag11455 Product name: Recombinant human LYG1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 23-194 aa of BC029126 Sequence: GCYGNIQSLDTPGASCGIGRRHGLNYCGVRASERLAEIDMPYLLKYQPMMQTIGQKYCMDPAVIAGVLSRKSPGDKILVNMGDRTSMVQDPGSQAPTSWISESQVSQTTEVLTTRIKEIQRRFPTWTPDQYLRGGLCAYSGGAGYVRSSQDLSCDFCNDVLARAKYLKRHGF Predict reactive species |
| Full Name | lysozyme G-like 1 |
| Calculated Molecular Weight | 194 aa, 21 kDa |
| GenBank Accession Number | BC029126 |
| Gene Symbol | LYG1 |
| Gene ID (NCBI) | 129530 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8N1E2 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The LYG1 Polyclonal antibody (Cat# 17474-1-AP) has 3 total citations. These appear in Advanced Science (2024), Small (2025), and Clinical and Translational Medicine (2025). The cited research spans ciliary biology and ARPKD protein regulation, skin regeneration via immunometabolic modulation of macrophages, and m6A-mediated epigenetic regulation in lung cancer. Applications include WB and ELISA in human samples.
| Species | Application | Title |
|---|---|---|
Adv Sci (Weinh) The ARPKD Protein DZIP1L Regulates Ciliary Protein Entry by Modulating the Architecture and Function of Ciliary Transition Fibers | ||
Small Decellularized ECM from Blastema Krt42⁺ Cells Promotes Skin Regeneration via Immunometabolic Modulation of Macrophages | ||
Clin Transl Med FTO-mediated m6A demethylation regulates IGFBP3 expression and AKT activation through IMP3-dependent P-body re-localisation in lung cancer |
